Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Taormina (Italy)

4 clinical trials in Taormina (Italy), Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Taormina (Italy) at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Taormina (Italy)

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Amgen Inc.

Malignant melanoma

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Taormina (Italy)

What the registry says about research in the country

01 Colorectal Cancer Research

Innovative clinical trials focusing on locally advanced rectal cancer are exploring the potential benefits of combining common medications with standard treatments. The research examines the effectiveness of neoadjuvant therapy approaches in improving patient outcomes before surgery.

  • Tumor Response Assessment
  • Combined Therapy Evaluation
  • Preoperative Treatment Options

These studies aim to enhance treatment effectiveness through strategic combinations of existing medications with chemotherapy and radiation therapy.

02 Melanoma Studies

Ground-breaking research in advanced melanoma treatment is evaluating novel immunotherapy combinations. These trials are specifically designed to assess the effectiveness of combined immunotherapy approaches in patients with resectable stage 3 or 4 disease.

  • Immunotherapy Combinations
  • Surgical Outcomes
  • Treatment Response Rates

The research focuses on improving treatment outcomes through peri-operative therapy strategies and innovative drug combinations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.